TuHURA Biosciences, Inc./NV 10-K

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities. Since August 20, 2020, our common stock has been listed on The Nasdaq Capital Market under the symbol “KTRA”. From July 12, 2016 until August 19, 2020 our common stock was listed on The Nasdaq Capital Market under the symbol “DMPI”. Previously, our common stock was quoted on the OTC.QX, and prior to that, on the OTCQB. As of September 23, 2021, there were approximately 502 holders of record of our common stock. Dividends We have never declared or paid any cash dividends on our common stock. We currently intend to retain future earnings, if any, to finance the expansion of our business. As a result, we do not anticipate paying any cash dividends in the foreseeable future. Sales of Unregistered Securities During the three months ended June 30, 2021, we issued 1,330 shares of common stock as dividends on our outstanding shares of Series B Preferred Stock, 14,898 shares of common stock from the cashless exercise of 31,215 warrants to purchase common stock, and two shares of Series C Preferred stock from the cashless exercise of Series C Agent warrants, The two shares of Series C Preferred stock were then converted into 1,725 shares of common stock. In connection with the foregoing, we relied upon the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended, for transactions not involving a public offering. Issuer Purchases of Equity Securities None. Item 6. Selected Financial Data. Not required for a smaller reporting company. 60